PATENT CLAIM ANALYSIS

Application Number: 16062358
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "461000"]

Abstract:
Disclosed is a pharmaceutical composition including naftazone or one of its pharmaceutically acceptable salts, for its use for the pulsatile release of naftazone or one of its pharmaceutically acceptable salts, wherein: a first pulse of naftazone or one of its pharmaceutically acceptable salts is released substantially immediately upon oral administration of the pharmaceutical composition; and at least one additional pulse of naftazone or one of its pharmaceutically acceptable salts is released at about 3 hours to about 8 hours following the oral administration.

Claim (Index 18):
A method for the pulsatile release of naftazone or one of its pharmaceutically acceptable salts, pharmaceutical composition comprising naftazone or one of its pharmaceutically acceptable salts, wherein:\n a first pulse of naftazone or one of its pharmaceutically acceptable salts is released substantially immediately upon oral administration of said pharmaceutical composition, and at least one additional pulse of naftazone or one of its pharmaceutically acceptable salts is released at about 3 hours to about 8 hours following said oral administration.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 2.09524
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14230053', '14841428', '14255529', '15076253', '14589839']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.730145370525478
- 35 USC 102 Novelty (BERT): 0.5154102535534044
- Combined Prediction Score: 0.7086718588282707
- Mean Citation Score: 298.387646
- Max Citation Score: 304.9656700000001
- Similarity Product: 212.9787233964396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test